We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

33 hedge funds and large institutions have $14.6M invested in Achieve Life Sciences in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

498% more call options, than puts

Call options by funds: $718K | Put options by funds: $120K

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

14% more funds holding

Funds holding: 29 → 33 (+4)

0.12% more ownership

Funds ownership: 20.31% → 20.43% (+0.12%)

2% less capital invested

Capital invested by funds: $14.9M → $14.6M (-$296K)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
8
Closed
2
Calls
$718K
Puts
$120K
Net Calls
+$598K
Net Calls Change
+$452K

Top Buyers

1
DAM
DLD Asset Management
New York
+$339K
2
LPL Financial
LPL Financial
California
+$131K
3
RJA
Raymond James & Associates
Florida
+$97.7K
4
Simplex Trading
Simplex Trading
Illinois
+$90.4K
5
Charles Schwab
Charles Schwab
California
+$76.7K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$362K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$148K
3
Citadel Advisors
Citadel Advisors
Florida
-$143K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$35.5K
5
SC
Shay Capital
New York
-$32.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Shay Capital
New York
$3.04M -$32.4K -4,349 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.6M -$21.4K -2,870 -0.8%
PCM
3
Perkins Capital Management
Minnesota
$1.32M – – –
6CM
4
683 Capital Management
New York
$946K – – –
ACM
5
Altium Capital Management
New York
$924K – – –
CC
6
Clearline Capital
New York
$909K -$14.3K -1,918 -2%
LPL Financial
7
LPL Financial
California
$655K +$131K +17,600 +26%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$647K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$609K -$148K -19,858 -20%
LFCM
10
Long Focus Capital Management
Puerto Rico
$454K – – –
DAM
11
DLD Asset Management
New York
$345K +$339K +45,528 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$306K -$7.45K -1,000 -2%
Franklin Resources
13
Franklin Resources
California
$257K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$191K +$10.4K +1,400 +6%
OC
15
Oppenheimer & Co
New York
$169K -$18.6K -2,500 -10%
State Street
16
State Street
Massachusetts
$142K +$29.6K +3,970 +27%
PVI
17
Pura Vida Investments
New York
$131K +$7.45K +1,000 +6%
Northern Trust
18
Northern Trust
Illinois
$129K +$633 +85 +0.5%
BlackRock
19
BlackRock
New York
$115K – – –
RJA
20
Raymond James & Associates
Florida
$99K +$97.7K +13,114 New
Two Sigma Advisers
21
Two Sigma Advisers
New York
$95K -$35.5K -4,770 -28%
Simplex Trading
22
Simplex Trading
Illinois
$94K +$90.4K +12,145 +3,562%
TPA
23
Trivium Point Advisory
Connecticut
$92K – – –
OQS
24
Occudo Quantitative Strategies
Florida
$83K – – –
Charles Schwab
25
Charles Schwab
California
$79K +$76.7K +10,306 New
1
2

ACHV Hedge Fund Activity: Q1 2022 in Review

33 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2022, worth a combined $14.6M — down 2% from $14.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ACHV positions and 2 closed out — a net gain of 4 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was DLD Asset Management, opening a new position worth an estimated $339K. The largest seller was Morgan Stanley, cutting an estimated $362K.

  • 33 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2022, up from 29 in Q4 2021.
  • Funds reported $14.6M of Achieve Life Sciences stock for Q1 2022, down 2% quarter-over-quarter.
  • 6 funds opened new Achieve Life Sciences positions in Q1 2022 and 2 closed out, a net change of +4 holders.
  • The largest Achieve Life Sciences buyer in Q1 2022 was DLD Asset Management, an estimated $339K added.
  • The largest Achieve Life Sciences seller in Q1 2022 was Morgan Stanley, an estimated $362K sold.

Based on aggregated 13F filings for Q1 2022.